Zoetis: In-Line Q4 Earnings And Weak Guidance Present A Buying Opportunity

Group 1 - Zoetis Inc. reported Q4 earnings that met consensus expectations, but the stock experienced a sharp sell-off in the morning session before recovering in the afternoon [1] - The primary concern affecting the stock was the slowing growth in revenue [1] Group 2 - The company has a history of significant investment and innovation in the biotechnology sector, with key personnel having extensive experience in pharmaceuticals and biotech startups [1]